LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 182 filers reported holding LEMAITRE VASCULAR INC in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $472,342 | -11.7% | 8,670 | +9.0% | 0.00% | – |
Q2 2023 | $534,943 | +9.4% | 7,951 | -16.3% | 0.00% | – |
Q1 2023 | $488,862 | -12.2% | 9,498 | -13.6% | 0.00% | – |
Q3 2022 | $557,000 | -20.2% | 10,991 | -28.3% | 0.00% | – |
Q2 2022 | $698,000 | +107.7% | 15,335 | +111.8% | 0.00% | – |
Q1 2022 | $336,000 | +29.2% | 7,239 | +47.7% | 0.00% | – |
Q3 2021 | $260,000 | -5.5% | 4,900 | +8.9% | 0.00% | – |
Q2 2021 | $275,000 | -7.7% | 4,500 | -26.2% | 0.00% | – |
Q1 2021 | $298,000 | +25.7% | 6,100 | -16.4% | 0.00% | – |
Q3 2020 | $237,000 | -16.5% | 7,300 | -7.6% | 0.00% | – |
Q4 2019 | $284,000 | +13.1% | 7,900 | +7.8% | 0.00% | – |
Q3 2019 | $251,000 | +9.6% | 7,330 | -24.4% | 0.00% | – |
Q4 2018 | $229,000 | -52.0% | 9,700 | -21.1% | 0.00% | – |
Q3 2018 | $477,000 | -14.5% | 12,300 | -44.2% | 0.00% | – |
Q4 2016 | $558,000 | – | 22,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |